My philosophy of care is that every patient's journey through their cancer is different, and, as providers, it is our responsibility to give them the best guidance through this process. Having the privilege of playing a major role in that journey is the most rewarding aspect of my job.
Oliver Eng, MD, FACS, is an Assistant Professor of Surgery at the University of Chicago. He is a double board-certified surgeon and surgical oncologist who focuses on the treatment of cancers in the abdomen, and in particular, cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) for locally advanced and metastatic cancers which have disseminated in the abdomen. HIPEC entails delivering high-dose heated chemotherapy in the operating room after surgical removal of visible disease, and is effective in different types of cancers.
Dr. Eng's research centers on better understanding the molecular and immunologic characteristics of peritoneal tumors, developing innovative therapies for metastatic disease, and optimizing outcomes and care in cancer patients. He has presented his work nationally and internationally, and he is the principal investigator or co-investigator on multiple clinical trials. He serves on the editorial board for a variety of scientific journals and has been appointed to a number of national committees.
Dr. Eng graduated from Brown University and attended Rutgers University - Robert Wood Johnson Medical School, where he also completed his general surgery residency. He completed a fellowship in complex general surgical oncology at City of Hope National Medical Center in California.
Verywell Health, a
is an award-winning online resource for reliable, empathetic, and up-to-date health information on medical
topics that matter most to you. We reach more than 300 million readers annually. Verywell Health content is
fact checked and reviewed by our
Medical Review Board
for accuracy and integrity. Learn more